LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 64 filers reported holding LEAP THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $13,529 | -69.3% | 39,790 | -59.4% | 0.00% | – |
| Q4 2022 | $44,131 | -65.3% | 98,069 | -11.4% | 0.00% | – |
| Q2 2022 | $127,000 | -86.4% | 110,683 | -79.3% | 0.00% | -100.0% |
| Q1 2022 | $934,000 | -81.0% | 533,748 | -64.8% | 0.00% | -70.0% |
| Q4 2021 | $4,915,000 | +309.2% | 1,517,045 | +406.4% | 0.01% | +233.3% |
| Q3 2021 | $1,201,000 | +157.2% | 299,600 | +21.9% | 0.00% | +200.0% |
| Q1 2021 | $467,000 | -45.3% | 245,750 | -35.2% | 0.00% | -50.0% |
| Q4 2020 | $853,000 | +8.2% | 379,106 | -4.7% | 0.00% | -33.3% |
| Q3 2020 | $788,000 | +330.6% | 397,908 | +353.7% | 0.00% | +200.0% |
| Q2 2020 | $183,000 | – | 87,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 150,142 | $268,000 | 0.02% |
| Alyeska Investment Group, L.P. | 514,285 | $921,000 | 0.01% |
| A.R.T. Advisors, LLC | 15,461 | $28,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 36,300 | $65,000 | 0.00% |
| Lindbrook Capital, LLC | 1,500 | $2,000 | 0.00% |
| US BANCORP \DE\ | 6,100 | $11,000 | 0.00% |
| Asset Planning Services, Ltd. | 100 | $0 | 0.00% |
| FMR LLC | 1,563,124 | $2,798,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 164,493 | $294,000 | 0.00% |